Chemistry Expert Witnesses in Georgia

This expert holds a Doctoral Degree in Health Science from the AT Still Osteopathic Medical University and a Master's Degree in Public Health, with a concentration in Disaster Medicine. Additionally, he is a Certified Industrial Hygienist, along with being a Certified Safety Professional. His areas of expertise are the chemistry of hazardous materials and chemical microscopy.

This expert has over 40 years of experience as a chemist. His research interests include electrochemistry, corrosion science, and physical chemistry. Elected as a Fellow of various organizations including the Institute of Corrosion, he was also nominated for the Nobel Prize in Chemistry. He currently serves as Professor in Residence in the Department of Materials Science and Engineering at a major university.

This highly qualified expert has years of experience in the field of neuropharmacology. He received his PhD degree from the University of California, Santa Barbara, and completed his fellowship training at Harvard University. He is a member of various professional associations, including the American Society of Pharmacology and Experimental Therapeutics and the American Chemical Society. He has published 250+ peer reviewed journal articles and has 51+ US issued patents that focus particularly on neurological studies. He also serves as the editor-in-chief for ACS Chemical Neuroscience, lectures both nationally and internationally and has received multiple honors for his outstanding work, including the John J. Abel award in pharmacology. He is the former co-director of the Synthesis Facility at the Vanderbilt Institute of Chemical Biology and the former senior organic chemist at Eli Lilly & Co. Currently, he is a professor of pharmacology and chemistry at a major university, where he is also the director of medicinal chemistry and DMPK at the Center for Neuroscience Drug Discovery. Additionally, he is the director of drug discovery at a major science institute in Tennessee.

This highly experienced expert in drug discovery and drug development earned his PhD in Pharmacology from Yale University and thereafter completed a postgraduate fellowship at the University of Michigan. He previously served as the Chief Scientific Officer of Adherex Technologies, International Vice President of Cancer Research at Glaxo Wellcome (now GSK) and Associate Division Director of Experimental Therapy at Burroughs Wellcome. He is a member of the American Chemical Society, the American Association for Cancer Research, and the American Society of Clinical Oncology. He has extensive experience in preclinical and clinical research and legal consulting.